Aratana Therapeutics (PETX) IPO Prices at $6/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Aratana Therapeutics (PETX) IPO Opens Higher
June 27, 2013 11:28 AM EDTThe IPO for Aratana Therapeutics (NASDAQ: PETX) opened for trading at $7 after pricing 5,750,000 share IPO at $6 per share, in-line with the expected pricing.
Stifel and Lazard Capital Markets are acting as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum... More



